CARRIER FOR TARGETING NERVE CELLS

CARRIER FOR TARGETING NERVE CELLS

New transport protein (A) obtained by modification of the heavy chain of a neurotoxin produced by Clostridium botulinum. Compared with the native neurotoxin (nNT) it: (a) binds with higher or lower affinity to nerve cells; (b) has higher/lower neurotoxicity, particularly as determined in the hemidia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANDREAS RUMMEL, TANJA WEIL, ALEKSANDRS GUTCAITS
Format: Patent
Sprache:eng ; por
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ANDREAS RUMMEL
TANJA WEIL
ALEKSANDRS GUTCAITS
description New transport protein (A) obtained by modification of the heavy chain of a neurotoxin produced by Clostridium botulinum. Compared with the native neurotoxin (nNT) it: (a) binds with higher or lower affinity to nerve cells; (b) has higher/lower neurotoxicity, particularly as determined in the hemidiaphragm assay; and/or (c) has lower affinity for neutralizing antibodies. Independent claims are also included for the following: (1) composition (C) comprising (A) and at least one intervening compound; (2) method for producing (A) or (C) by standard recombinant methods; (3) host cells that contain a recombinant expression vector (EV) encoding (A) or (C); and (4) EV. ACTIVITY : Relaxant; Antimigraine; Analgesic; Vulnerary; Antidepressant; Virucide. No details of tests for these activities are given. MECHANISM OF ACTION : Delivering agents that inhibit release of neurotransmitters.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT3181578TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT3181578TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT3181578TT3</originalsourceid><addsrcrecordid>eNrjZFB0dgwK8nQNUnDzD1IIcQxydw3x9HNX8HMNCnNVcHb18QnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASHGhhaGpuYWISHGRCgBANhZIkM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CARRIER FOR TARGETING NERVE CELLS</title><source>esp@cenet</source><creator>ANDREAS RUMMEL ; TANJA WEIL ; ALEKSANDRS GUTCAITS</creator><creatorcontrib>ANDREAS RUMMEL ; TANJA WEIL ; ALEKSANDRS GUTCAITS</creatorcontrib><description>New transport protein (A) obtained by modification of the heavy chain of a neurotoxin produced by Clostridium botulinum. Compared with the native neurotoxin (nNT) it: (a) binds with higher or lower affinity to nerve cells; (b) has higher/lower neurotoxicity, particularly as determined in the hemidiaphragm assay; and/or (c) has lower affinity for neutralizing antibodies. Independent claims are also included for the following: (1) composition (C) comprising (A) and at least one intervening compound; (2) method for producing (A) or (C) by standard recombinant methods; (3) host cells that contain a recombinant expression vector (EV) encoding (A) or (C); and (4) EV. ACTIVITY : Relaxant; Antimigraine; Analgesic; Vulnerary; Antidepressant; Virucide. No details of tests for these activities are given. MECHANISM OF ACTION : Delivering agents that inhibit release of neurotransmitters.</description><language>eng ; por</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190527&amp;DB=EPODOC&amp;CC=PT&amp;NR=3181578T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190527&amp;DB=EPODOC&amp;CC=PT&amp;NR=3181578T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANDREAS RUMMEL</creatorcontrib><creatorcontrib>TANJA WEIL</creatorcontrib><creatorcontrib>ALEKSANDRS GUTCAITS</creatorcontrib><title>CARRIER FOR TARGETING NERVE CELLS</title><description>New transport protein (A) obtained by modification of the heavy chain of a neurotoxin produced by Clostridium botulinum. Compared with the native neurotoxin (nNT) it: (a) binds with higher or lower affinity to nerve cells; (b) has higher/lower neurotoxicity, particularly as determined in the hemidiaphragm assay; and/or (c) has lower affinity for neutralizing antibodies. Independent claims are also included for the following: (1) composition (C) comprising (A) and at least one intervening compound; (2) method for producing (A) or (C) by standard recombinant methods; (3) host cells that contain a recombinant expression vector (EV) encoding (A) or (C); and (4) EV. ACTIVITY : Relaxant; Antimigraine; Analgesic; Vulnerary; Antidepressant; Virucide. No details of tests for these activities are given. MECHANISM OF ACTION : Delivering agents that inhibit release of neurotransmitters.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB0dgwK8nQNUnDzD1IIcQxydw3x9HNX8HMNCnNVcHb18QnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASHGhhaGpuYWISHGRCgBANhZIkM</recordid><startdate>20190527</startdate><enddate>20190527</enddate><creator>ANDREAS RUMMEL</creator><creator>TANJA WEIL</creator><creator>ALEKSANDRS GUTCAITS</creator><scope>EVB</scope></search><sort><creationdate>20190527</creationdate><title>CARRIER FOR TARGETING NERVE CELLS</title><author>ANDREAS RUMMEL ; TANJA WEIL ; ALEKSANDRS GUTCAITS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT3181578TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ANDREAS RUMMEL</creatorcontrib><creatorcontrib>TANJA WEIL</creatorcontrib><creatorcontrib>ALEKSANDRS GUTCAITS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANDREAS RUMMEL</au><au>TANJA WEIL</au><au>ALEKSANDRS GUTCAITS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CARRIER FOR TARGETING NERVE CELLS</title><date>2019-05-27</date><risdate>2019</risdate><abstract>New transport protein (A) obtained by modification of the heavy chain of a neurotoxin produced by Clostridium botulinum. Compared with the native neurotoxin (nNT) it: (a) binds with higher or lower affinity to nerve cells; (b) has higher/lower neurotoxicity, particularly as determined in the hemidiaphragm assay; and/or (c) has lower affinity for neutralizing antibodies. Independent claims are also included for the following: (1) composition (C) comprising (A) and at least one intervening compound; (2) method for producing (A) or (C) by standard recombinant methods; (3) host cells that contain a recombinant expression vector (EV) encoding (A) or (C); and (4) EV. ACTIVITY : Relaxant; Antimigraine; Analgesic; Vulnerary; Antidepressant; Virucide. No details of tests for these activities are given. MECHANISM OF ACTION : Delivering agents that inhibit release of neurotransmitters.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT3181578TT
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title CARRIER FOR TARGETING NERVE CELLS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A01%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANDREAS%20RUMMEL&rft.date=2019-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT3181578TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true